St. Jude, Boston Scientific ICD Sales Growth Flat-Lines In Q3 – Rebound In ’07?

St. Jude Medical is more than halfway through a planned 500-rep expansion of its U.S. implantable cardioverter defibrillator sales force as part of its broader effort to reignite ICD sales growth

More from Archive

More from Medtech Insight